The controversial effect of smoking and nicotine in SARS-CoV-2 infection

The effects of nicotine and cigarette smoke in many diseases, notably COVID-19 infection, are being debated more frequently.

The current basic data for COVID-19 is increasing and indicating the higher risk of COVID-19 infections in smokers due to the overexpression of corresponding host receptors to viral entry.

However, current multi-national epidemiological reports indicate a lower incidence of COVID-19 disease in smokers.

Current data indicates that smokers are more susceptible to some diseases and more protective of some other.

Interestingly, nicotine is also reported to play a dual role, being both inflammatory and anti-inflammatory.

In the present study, we tried to investigate the effect of pure nicotine on various cells involved in COVID-19 infection.

We followed an organ-based systematic approach to decipher the effect of nicotine in damaged organs corresponding to COVID-19 pathogenesis (12 related diseases).

Considering that the effects of nicotine and cigarette smoke are different from each other, it is necessary to be careful in generalizing the effects of nicotine and cigarette to each other in the conducted researches.

The generalization and the undifferentiation of nicotine from smoke is a significant bias.

Moreover, different doses of nicotine stimulate different effects (dose-dependent response).

In addition to further assessing the role of nicotine in COVID-19 infection and any other cases, a clever assessment of underlying diseases should also be considered to achieve a guideline for health providers and a personalized approach to treatment.